Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • guzhi100
    Member
    • Feb 2012
    • 15

    Tophat mapping

    Hi,

    After mapping RNA-Seq paired end reads with Tophat, I can see that most of reads fall into the right regions. However, I still can see lots of reads mapped to non-coding region (the locations where the reads are mapped to don't contain exons).

    I am wondering if these "non-coding reads" will be included when cufflinks calculates transcript/gene expression.
    Dying to know your opinion.

    And another question is: how to know the number of reads mapped to a certain exon?

    Thanks
  • ETHANol
    Senior Member
    • Feb 2010
    • 308

    #2
    Originally posted by guzhi100 View Post
    Hi,

    After mapping RNA-Seq paired end reads with Tophat, I can see that most of reads fall into the right regions. However, I still can see lots of reads mapped to non-coding region (the locations where the reads are mapped to don't contain exons).

    I am wondering if these "non-coding reads" will be included when cufflinks calculates transcript/gene expression.
    Dying to know your opinion.

    And another question is: how to know the number of reads mapped to a certain exon?

    Thanks
    HTseq-count can assign your mapped reads to whatever you like as long as you have a GTF file. Check DEXseq, there's info about exon specific mapping there.
    --------------
    Ethan

    Comment

    • Camg
      Member
      • Jan 2011
      • 21

      #3
      What organism are you mapping to?
      Can you be more specific about the "non-coding regions", such as: are the reads mapping adjacent to coding regions (ie within a few hundred bp's)? are they mapping between coding regions that are close together? or are they mapping to regions that are basically in the middle or nowhere with nothing annotated nearby (at least a few kb away)? and, what kind of depth of coverage do you see in these non-coding regions?
      Depending on the "compactness" of the genome you might see what looks like reads mapping to non-coding regions simply because of the proximity to coding regions. Or you might just have novel transcribed regions.

      You can tell cufflinks whether you want it to assemble novel transcripts and give you counts for those (default), or whether you want it to only count expression for the genes that you give it in a GTF file (use the -G or --GTF option).

      I've used HTseq and it works well.

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Today, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...